DUBLIN, Dec. 15, 2023 /PRNewswire/ — The “Oxidative Stress Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2026” report has been added to ResearchAndMarkets.com’s offering.
The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, the publisher expects the market to grow at a CAGR of 9.7% during 2023-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Oxidative stress is a health condition wherein excessive production of oxygen-derived free radicals within a cell or organism overwhelms the intrinsic antioxidant defenses. It causes oxidative damage to proteins, lipids and nucleic acids, which can further lead to the development of cancer, asthma, ischemia, diabetes, and cardiovascular and neurodegenerative diseases. It is assessed using a number of assays that help healthcare researchers gain a better understanding of the mechanisms and responses of the condition.
Free radicals can be produced due to biological factors, unhealthy dietary habits and air pollution. This, in confluence with the rising number of individuals who smoke and consume alcohol, is escalating the risk of developing oxidative stress, which, in turn, is strengthening the market growth. Apart from this, the development of various pathologic conditions and acceleration of the aging process on account of oxidative stress is also bolstering the market growth.
Furthermore, the growing biopharmaceutical industry, increasing investments in the research and development (R&D) activities and technological advancements, such as high-content screening for drug discovery, are acting as other major factors stimulating the market growth. Moreover, oxidative stress is also being considered as a major factor contributing to the severity of the coronavirus disease (COVID-19). It is also being evaluated as a probable cause of multi-organ failure among patients. The ongoing studies on the interrelation between the disease and oxidative stress are expected to positively influence the market growth.
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abcam PLC, AMS Biotechnology (Europe) Ltd., Biovision Inc. (Boai NKY Medical Holdings Ltd.), Cell Biolabs Inc., Enzo Biochem Inc., ImmunoChemistry Technologies LLC, Merck KGaA, Oxford Biomedical Research, Promega Corporation, Qiagen N.V. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global oxidative stress assay market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global oxidative stress assay market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global oxidative stress assay market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Oxidative Stress Assay Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents and Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 ELISA (Enzyme-Linked Immunosorbent Assay)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Flow Cytometry
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Chromatography
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Microscopy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 High-Content Screening
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Label-Free Detection
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Test Type
8.1 Indirect Assays
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Protein-Based Assays
8.1.2.2 Lipid-Based Assays
8.1.2.3 Nucleic Acid-Based Assays
8.1.3 Market Forecast
8.2 Antioxidant Capacity Assays
8.2.1 Market Trends
8.2.2 Major Types
8.2.2.1 Glutathione Assays
8.2.2.2 Ascorbic Acid Assays
8.2.2.3 Cell-Based Exogenous Antioxidant Assays
8.2.3 Market Forecast
8.3 Enzyme-Based Assays
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Reactive Oxygen Species-Based Assays
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Industry
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abcam PLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AMS Biotechnology (Europe) Ltd.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Biovision Inc. (Boai NKY Medical Holdings Ltd.)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Cell Biolabs Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Enzo Biochem Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 ImmunoChemistry Technologies LLC
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Biomedical Research
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Promega Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Qiagen N.V.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/u3l4ag
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
